Senate
House
Joint
Bill Status
WV Code
Audits/ Reports
Educational
Contact
home
home

SB7 SUB1 Senate Bill 7 History

OTHER VERSIONS  -  Introduced Version  |  DOWNLOAD  wpd  |  Email


COMMITTEE SUBSTITUTE

FOR

Senate Bill No. 7

(By Senators Stollings, Jenkins, Miller, Plymale, Foster, Klempa and Kirkendoll)

____________

[Originating in the Committee on Health and Human Resources;

reported January 18, 2012.]

____________

 

A BILL to amend the Code of West Virginia, 1931, as amended, by adding thereto a new section, designated §16-4C-24, relating generally to allowing State Police, police, sheriffs and fire and emergency service personnel to possess Naloxone to administer in suspected narcotic drug overdoses; defining terms; providing for training; granting immunity to health care providers who prescribe Naloxone related to a training program; granting immunity to initial responders; providing for data gathering and reporting; and authorizing legislative or emergency rulemaking.

Be it enacted by the Legislature of West Virginia:

    That the Code of West Virginia, 1931, as amended, be amended by adding thereto a new section, designated §16-4C-24, to read as follows:

CHAPTER 16. PUBLIC HEALTH.

ARTICLE 4C. EMERGENCY MEDICAL SERVICES ACT.

§16-4C-24. Administration of an opioid antidote in an emergency               situation.

    (a) For purposes of this section:

    (1) “Initial responder” means any emergency medical service personnel covered under this article and any member of the state police, any sheriff, any deputy sheriff, any municipal police officer, any volunteer and paid firefighters, and any other similar persons who respond to emergencies.

    (2) “Licensed health care provider” means a person, partnership, corporation, professional limited liability company, health care facility or institution licensed by, or certified in this state to provide health care or professional health care services, including but not limited to a physician, osteopathic physician, hospital, or emergency medical service agency.

    (3) "Opioid antagonist" means naloxone hydrochloride that is approved by the federal Food and Drug Administration for the treatment of a drug overdose by intranasal administration.

    (4) "Opioid overdose prevention and treatment training program" or "program" means any program operated or approved by the Office of Emergency Medical Services to train individuals to prevent, recognize, and respond to an opiate overdose, and that provides, at a minimum, training in all of the following:

    (A) The causes of an opiate overdose;

    (B) How to contact appropriate emergency medical services; and

    (C) How to administer an opioid antagonist.

    (b) A licensed health care provider who is permitted by law to prescribe an opioid antagonist may, if acting with reasonable care, prescribe and subsequently dispense or distribute an opioid antagonist in conjunction with an opioid overdose prevention and treatment training program, without being subject to civil liability or criminal prosecution, unless the act was the result of the licensed health care provider’s gross negligence or wilful misconduct. This immunity shall apply to the licensed health care provider even when the opioid antagonist is administered by and to someone other than the person to whom it is prescribed.

    (c) Any initial responders, who are not otherwise licensed to administer an opioid antagonist, may administer an opioid antagonist in an emergency without fee if the person has received the training specified in subdivision (4) of subsection (a) of this section and believes in good faith that the person being treated is experiencing an opiate overdose. The initial responder identified in this subsection, acting in good faith, is not, as a result of his or her acts or omissions, liable for any violation of any professional licensing statute, or subject to any criminal prosecution arising from or relating to the unauthorized practice of medicine or the possession of an opioid antagonist, or subject to any civil liability with respect to the administration of or failure to administer the opioid antagonist unless the act or failure to act was the result of the initial responder’s gross negligence or wilful misconduct.

    (d) Data regarding each opioid overdose prevention and treatment program that the Office of Emergency Medical Services operates or recognizes as an approved program shall be collected and reported by January 1, 2016 to the Legislative Oversight Commission on Health and Human Resources Accountability. The data collected and reported shall include:

    (1) Number of training programs operating in the local health jurisdiction;

    (2) Number of individuals who have received a prescription for, and training to administer, an opioid antagonist;

    (3) Number of opioid antagonist doses prescribed;

    (4) Number of opioid antagonist doses administered;

    (5) Number of individuals who received the opioid antagonist who were properly revived;

    (6) Number of individuals who received the opioid antagonist who were not revived;

    (7) Number of adverse events associated with an opioid overdose prevention and treatment program, including a description of the adverse events.

    (f) To implement the provisions of this section, including establishing the standards for certification and approval of opioid overdose prevention and treatment training programs, the Office of Emergency Medical Services shall promulgate emergency rules pursuant to the provisions of section fifteen, article three, chapter twenty-nine-a of this code or propose rules for legislative approval in accordance with the provisions of article three, chapter twenty-nine-a of this code.

This Web site is maintained by the West Virginia Legislature's Office of Reference & Information.  |  Terms of Use  |   Web Administrator   |   © 2014 West Virginia Legislature **